Zuellig Pharma’s Post

Our Sustainability Sub-Team is making great progress at pace! With active participation from 11 member companies and leadership from Duncan Paterson, CEng, MBA and Monica Adams, the team developed ambitious goals for 2024.  Two main deliverables to address identified knowledge gaps are being actively advanced in a precompetitive manner. The first workstream, led by Conor ONeill and Sascha Rau, is focused on benchmarking the adoption of sustainability practices within the product development functions across the member companies and expects to read out later this year. The second workstream, under Dragana CVIJANOVIC, involves a patient-focused research study in collaboration with the Consortium’s Patient Preference and Patient Experiences Sub-Team, led by Jennie Stevenson and Johanna Schoss. The goal of the research for the sustainability workstream, is to understand user expectations and concerns about the environmental sustainability of subcutaneous pharmaceuticals, as well the level of interest and engagement users have in programs and products designed to minimize environmental impact. We look forward to seeing the product of the Sub-Team's work and would like to acknowledge all of the contributing members: Christian Pommereau and Karsten Tritsch (Sanofi); Dragana CVIJANOVIC and Amit Limaye (BD) Duncan Paterson, CEng, MBA and Zahid Nazir (AstraZeneca); Sascha Rau (Boehringer Ingelheim); James Glover (Pfizer); Conor ONeill, Mahdieh Bashoor Zadeh, and Monica Adams (GSK); Wail Rasheed, Ph.D. (Merck); Kevin Swanson (Halozyme, Inc.); and Sylvain L. Lanzi (Novartis). #SCConsortium #sustainability #drugdelivery #drugdevelopment

🌿 Exciting news in healthcare sustainability! Takeda and Boston Medical Center (BMC) join forces to tackle hard-to-abate greenhouse gas emissions in the healthcare sector. 🏥🌍 This innovative partnership aims to: 🗑️ Reduce emissions from regulated medical waste disposal ♻️ Focus on pharmaceutical packaging and single-use plastics 📊 Share best practices to scale solutions industry-wide "Our collaboration with Takeda aims to drive meaningful change by tackling environmental challenges that contribute to health disparities in many communities," says Robert Biggio, SVP at BMC Health System. Read more on this: https://lnkd.in/ehKZ4qSe Together, they're paving the way for a greener, healthier future in healthcare! 📰 Stay ahead in healthcare by following Practical Patient Care on LinkedIn! Get the latest news and insights on patient care and clinical advancements. Join our community to stay informed and enhance your knowledge. Follow us today! #PracticalPatientCare #SustainableHealthcare #ClimateAction #IndustryCollaboration

Those conversation about sustainability in the pharma industry are so important to have. If this is of interest to you, I'd love to have a chat! #sustainability

For us at the Vitrolife Group, sustainability means striving to make a difference for our people, our customers, their patients, the planet, and society. We believe in making long-term business decisions rooted in our core values and purpose. We have developed a long-term strategy, approved by the Board of Directors, centred around four pillars: 🍀Focusing on our mission and purpose to benefit our customers and their patients. 🍀Ensuring ethical behaviour in all our business activities and partnerships, without compromise. 🍀Respect for the planet and accountability for our environmental impact. 🍀Fostering a sense of belonging and engagement among our people, allowing everyone to bring their best selves to work. Our mantra is ensuring sustainability in everything we do, and we make every action count. Together, let’s work towards a sustainable future, creating a lasting impact for generations to come. More information on our sustainability approach is available in our website: https://ow.ly/l9vw50TSkIl #VitrolifeGroup #Vitrolife #Igenomix #WorldSustainabilityday#SustainabilityInEverythingWeDo

🌱 𝐒𝐮𝐬𝐭𝐚𝐢𝐧𝐚𝐛𝐢𝐥𝐢𝐭𝐲 – 𝐆𝐨𝐚𝐥𝐬 𝐚𝐧𝐝 𝐁𝐞𝐬𝐭 𝐏𝐫𝐚𝐜𝐭𝐢𝐜𝐞𝐬 | 𝐑𝐞𝐧𝐭𝐬𝐜𝐡𝐥𝐞𝐫 𝐁𝐢𝐨𝐩𝐡𝐚𝐫𝐦𝐚 Climate change and limited natural resources are among the greatest challenges of our time. The gradual transition to a more sustainable, climate-friendly and resource-friendly society is both difficult and inevitable. 🌍   Over the next few weeks, we would like to highlight the areas in which the BioPharma Cluster South Germany members are driving this sustainable transformation forward today with Rentschler Biopharma.   At Rentschler Biopharma, we aim for the highest quality standards, considering sustainability's environmental and socio-economic aspects as an integral part of everything we do. As an internationally operating CDMO, we have dedicated all our expertise and passion to the production of high quality biopharmaceuticals, enabling our clients to help patients with rare and serious diseases. However, we must be aware that the production of biopharmaceuticals has an impact on the environment.   With more than 150 years of history, we are committed to creating sustainable value for our clients, business, employees, supply chain, environment and the society. Sustainability and responsibility are an important part of our corporate strategy. We want to contribute to achieving the 17 Sustainable Development Goals (SDGs) adopted by the United Nations. To emphasize our commitment, we joined the UN Global Compact, the world’s largest corporate sustainability initiative.   Our holistic sustainability strategy focuses on three dimensions: Environment, Social Sustainability and Governance.   We aim to significantly reduce our CO2 emissions and therefore joined the Science Based Target initiative (SBTi). In addition, the health and safety of our employees is a priority. We provide a safe, diverse and respectful working environment for all and offer our employees various benefits like fitness courses or mobility tickets for public transportation. We also set up an interdisciplinary sustainability team to support internal initiatives and raise awareness for sustainability topics among our workforce. Responsibility, compliance and integrity are the cornerstones of our business. As our understanding of sustainability is not limited to our own area of business, we engage our suppliers to foster sustainability in our supply chains.   For our efforts we were awarded a silver medal in the prestigious Ecovadis sustainability rating placing us among the top 15 percent of companies rated by Ecovadis in the last 12 months.   ---   The BioPharma Cluster South Germany creates an attractive, cross-functional and innovation-driven environment for the research, development and production of biopharmaceuticals and therapies. By focusing on technology, talent and society, we strengthen healthcare as a whole for the benefit of patients worldwide.   #BioPharma #Health #Sustainability #BPCluster #BioPharmaSustain

Interested in learning more about our sustainability strategy and initiatives? Then read this post, which was created in collaboration with the BioPharma Cluster South Germany. 

Amgen’s 2023 Environmental, Social & Governance Report has me thinking about our organization’s collective impact and how the progress we’ve made towards reaching our ESG goals helps us support a healthier planet and in turn a healthier patient population. For more than four decades, we have established a record of reliably supplying high-quality medicines to patients. Quality and sustainability are not simply boxes we check; they are in our company's DNA. This year’s ESG report provides us an opportunity to showcase our progress year over year and reaffirm our dedication to a healthier future. To read the full report, please click here. #mycompany #Amgen #Sustainability

Working in Healthcare Sustainability is more than thermostats, tides and tornados, it's about improving the health and well-being of people at scale. Clarivate and Teva partnered to do just this. "By encouraging the proper use and disposal of commonly used antibiotics, this large-scale communication program has the potential to educate patients and in doing so, create a measurable impact on patient lives,” says Amalia Adler-Waxman, SVP, Global Head, ESG, Teva.  https://lnkd.in/ebhEnjbJ Who Cares Wins

For us at the Vitrolife Group, sustainability means striving to make a difference for our people, our customers, their patients, the planet, and society. We believe in making long-term business decisions rooted in our core values and purpose. We have developed a long-term strategy, approved by the Board of Directors, centred around four pillars: 🍀Focusing on our mission and purpose to benefit our customers and their patients. 🍀Ensuring ethical behaviour in all our business activities and partnerships, without compromise. 🍀Respect for the planet and accountability for our environmental impact. 🍀Fostering a sense of belonging and engagement among our people, allowing everyone to bring their best selves to work. Our mantra is ensuring sustainability in everything we do, and we make every action count. Together, let’s work towards a sustainable future, creating a lasting impact for generations to come. More information on our sustainability approach is available in our website: https://ow.ly/pN4F50TQsKJ #VitrolifeGroup #Vitrolife #Igenomix #WorldSustainabilityday#SustainabilityInEverythingWeDo

TIME and Statista conducted a comprehensive analysis to identify the World’s Best Companies In Sustainable Growth 2025. So proud to see AstraZeneca included in this ranking, recognised for our strong financial and environmental performance. LINK: https://lnkd.in/eCybTp26 #TimeMagazine #Sustainability #WhatScienceCanDo